ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 78 filers reported holding ITEOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,315,257 | +5.0% | 358,171 | -3.5% | 0.00% | 0.0% |
Q1 2024 | $5,061,818 | +139.0% | 371,101 | +91.9% | 0.00% | +100.0% |
Q4 2023 | $2,117,741 | +222.9% | 193,401 | +222.9% | 0.00% | – |
Q3 2023 | $655,905 | -34.6% | 59,900 | -20.9% | 0.00% | – |
Q2 2023 | $1,002,414 | +75611.0% | 75,711 | -22.2% | 0.00% | – |
Q1 2023 | $1,324 | -24.2% | 97,282 | +8.8% | 0.00% | -100.0% |
Q4 2022 | $1,746 | -99.9% | 89,428 | -10.7% | 0.00% | 0.0% |
Q3 2022 | $1,907,000 | -59.6% | 100,104 | -56.3% | 0.00% | -50.0% |
Q2 2022 | $4,723,000 | -29.6% | 229,277 | +12.4% | 0.00% | 0.0% |
Q1 2022 | $6,709,000 | -5.6% | 203,914 | +7.7% | 0.00% | 0.0% |
Q4 2021 | $7,109,000 | +132.1% | 189,348 | +77.7% | 0.00% | +100.0% |
Q3 2021 | $3,063,000 | +10.3% | 106,549 | -1.6% | 0.00% | 0.0% |
Q2 2021 | $2,778,000 | -35.4% | 108,312 | -13.9% | 0.00% | 0.0% |
Q1 2021 | $4,299,000 | +131.1% | 125,772 | +128.7% | 0.00% | 0.0% |
Q4 2020 | $1,860,000 | +233.3% | 54,988 | +143.0% | 0.00% | – |
Q3 2020 | $558,000 | – | 22,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |